Takeda myPNtracker Mobile app for patients with short bowel syndrome

Main articles:

• Short bowel syndrome
• Mobile Applications

2021: Creating an Application myPNtracker

On September 17, 2021, Takeda announced the development of a mobile application myPNtracker to help the doctor and patient in assessing the health of patients with short bowel syndrome (CCS).

The application is designed to improve the quality of life of people with CCM. In myPNtracker, the patient can record data his condition daily, as well as indicate the doctor who will exercise control over the course of his disease.

The app will myPNtracker help patients control important indicators of their body, and treating doctors - view summary data and monitor dynamics and trends. The development of technologies does not stand still, we try to use all opportunities to improve the quality of life and well-being of patients, "said Dmitry Koloda, medical director of Takeda Russia.

Short bowel syndrome is an extremely rare, chronic, leading to disability and potentially life-threatening condition in which a person cannot absorb enough nutrients and trace elements from food for survival due to loss of intestinal absorption ability. This condition develops as a result of extensive resection of the intestine, the causes of which can be injuries, various bowel diseases (for example, Crohn's disease), vascular complications; or congenital malformations. Worldwide, the prevalence of short bowel syndrome with intestinal insufficiency (CCS-CH) varies from 1 to 5 cases per 1 million people.

Patients with CCS-CH vital need parenteral nutrition (PP) and infusion therapy (IT). This is a high-cost long-term treatment that limits the patient in moving and conducting a full-fledged lifestyle. Manifestations of CCS-CN and complete dependence on parenteral nutrition can lead to the development of serious complications, such as infections and sepsis, thrombosis and liver damage, as well as a significant deterioration in the quality of life.

People with short bowel syndrome suffer from a variety of debilitating symptoms, including dehydration, diarrhea, fatigue, and weakness. A study of gastroenterologists from covering a Great Britain 30-year history of sightings of CCM-CN patients notes a high lethality among patients on lifetime PP/IT with reduced survival rates over time.

Therefore, it is important for the patient to be in touch with the attending physician, to share information about the amount of liquids and substances consumed, such as: oral fluids, oral rehydration solutions, intravenous rehydration fluid, dietary supplements, intravenous nutritional mixtures, to convey data about their weight and well-being. All this can be done in the appendix myPNtracker. Tracking the progress of the disease will help the Reports function, which allows you to see a graph of changes in data for a day or week. You can also create - with PDFfile the selected data and send it to the address e-mail. Dunning Function reports about the planned visit to the doctor, taking medicines and uploading daily data to the application. If the patient receives injectable drug therapy, the myPNtracker may retain information information about the sites of administration of the four last injections to prevent the use of the same area for drug administration. In addition, the application has functions such as the "Water Balance Journal," where you can compare the total volume of liquids consumed and released in 24 hours or 48 hours. The frequency of tracking is established by a medical specialist.

For the convenience of interaction between doctors and patients, a special web portal was created for medical specialists. On the site, a medical specialist will be able to generate reports on certain parameters and track the dynamics of the disease.

The app is myPNtracker available for free download on iOS and Android devices. To install it, in the appropriate store, enter the name of the application in the search string or use the QR code.